Submit an Application

Application and Grant process

The ATS Early Career Investigator Award in Pulmonary Vascular Disease Young Investigator Program is a US-based research program consistent with Janssen Pharmaceutical Company of Johnson & Johnson’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease.

Individual grants of up to $100,000 are provided to qualified investigators to conduct research on the basic mechanisms and/or vascular biology of pulmonary vascular disease via a 12-month mentored grant. Grants are awarded by the ATS Early Career Investigator Award in Pulmonary Vascular Disease Steering Committee and based on scientific merit, originality, feasibility, and applicability to the diagnosis and treatment of pulmonary hypertension.

The application process is simple:

1. Click on the link below to start the application process. Complete your application.
2. Once your application is complete, you can begin your grant submission by clicking on the application forms here. Applicants should download the Grant Submission Form and Budget/Justification Form to their computer to complete. Once your grant submission is final, you can upload your submission to your application.

*Please note that mentorship for this YI program is a critical component of eligibility, as well as an important criterion for a competitive application. Adequate mentorship and strong support from both your institution and mentor are required for a successful application.

The Grant submission must be submitted electronically via the ATS Early Career Investigator Award in Pulmonary Vascular Disease Web site.

Applicant forms are available here

Details about the ATS Early Career Investigator Award in Pulmonary Vascular Disease Program Overview, Eligibility and Grant Guidelines are described in the links below:

Program Overview
Program Overview

Investigator and project eligibility guidelines are available here:

The grant submission process, guidelines, supporting documents, reports, and other details are available here:
Grant Submission Guidelines

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498

© 1998 - American Thoracic Society, all rights reserved.